Arrayit Hires Docro to Smooth FDA Path for OvaDx Test
March 23, 2010
Arrayit Hires Docro to Smooth FDA Path for OvaDx Test
Arrayit is hoping to submit OvaDx, an array-based pre-symptomatic ovarian cancer test that includes 100 proteomic biomarkers, to the FDA later this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.